Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type-natriuretic peptide/long non-coding RNA LSINCT5/caspase-1/interleukin 1β signaling pathway

Zhang,Xian; Sha,Minglei; Yao,Yuting; Da,Jia; Jing,Dadao

doi:10.3892/mmr.2015.4247

Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type-natriuretic peptide/long non-coding RNA LSINCT5/caspase-1/interleukin 1β signaling pathway

Authors:
- Xian Zhang
- Minglei Sha
- Yuting Yao
- Jia Da
- Dadao Jing
View Affiliations

Affiliations: Department of Geriatrics, Shanghai First People's Hospital, Shanghai 200080, P.R. China
Published online on: August 25, 2015 https://doi.org/10.3892/mmr.2015.4247
Pages: 6761-6767
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic heart failure (CHF) is the final stage of various heart diseases, and is increasingly recognized as a major health problem in the elderly. Previous studies demonstrated that B‑type‑natriuretic peptide (BNP) is an established biomarker of CHF. Furthermore, BNP also regulates cell proliferation, differentiation and apoptosis. Recent evidence has revealed that BNP affects myocardial cell apoptosis during myocardial ischemia‑reperfusion injury. Long non‑coding RNAs (lncRNAs) are emerging as novel molecular compounds involved in gene regulation, and have important roles in numerous human diseases. However, the mechanism underlying the BNP and lncRNA-induced regulation of myocardial cell apoptosis remains to be elucidated. The present study reported that lncRNA LSINCT5, upregulated by BNP, is able to regulate myocardial cell apoptosis via the activation of the caspase‑1/interleukin (IL)‑1β signaling pathway. BNP-induced apoptosis of HCM cells was observed using flow cytometry, and involved caspase‑1. In addition, expression profiling using a human lncRNA polymerase chain reaction array revealed that LSINCT5 was highly expressed in BNP-treated myocardial cells, as compared with untreated cells. The role of lncRNA LSINCT5 in HCM cell apoptosis was also investigated. The results of the present study indicated that LSINCT5 silencing by small interfering RNA inhibits caspase‑1/IL‑1β signaling, and suppresses apoptosis in BNP-treated HCM cells. Therefore, high expression levels of BNP promote the apoptosis of myocardial cells through the lncRNA LSINCT5 mediator, which activates the caspase‑1/IL‑1β signaling pathway. These findings uncovered a novel pathogenic mechanism, and provided a potential therapeutic target for CHF.

View Figures

View References

1	Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA and Swedberg K; CHARM Investigators Committees: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial. Lancet. 362:772–776. 2003. View Article : Google Scholar : PubMed/NCBI
2	Gu D, Huang G and He J: Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Zhonghua Xin Xue Guan Bing Za Zhi. 31:3–6. 2002.In Chinese.
3	Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al American College of Cardiology Foundation; American Heart Association: Task Force on Practice Guidelines: 2013 ACCF/AHA guideline for the management of heart failure: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol. 62:e147–e239. 2013. View Article : Google Scholar : PubMed/NCBI
4	Cowie MR: BNP-guided therapy for chronic heart failure: Anything more than just an attractive concept? Eur Heart J. 35:1507–1509. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ishino M, Takeishi Y, Niizeki T, Watanabe T, Nitobe J, Miyamoto T, Miyashita T, Kitahara T, Suzuki S, Sasaki T, et al: Risk stratification of chronic heart failure patients by multiple biomarkers: Implications of BNP, H-FABP and PTX3. Circ J. 72:1800–1805. 2008. View Article : Google Scholar : PubMed/NCBI
6	Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, et al ESC Committee for Practice Guidelines (CPG): ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 10:933–989. 2008. View Article : Google Scholar : PubMed/NCBI
7	O'Shea P, Daly R, Kasim S and Tormey WP: B-Type natriuretic peptide in the cardiology department. Ir Med J. 105:341–343. 2012.
8	Porapakkham P, Zimmet H, Billah B and Krum H: B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. Arch Intern Med. 170:507–514. 2010. View Article : Google Scholar : PubMed/NCBI
9	Szondy Z: Methylprednisolone and 2-chloroadenosine induce DNA fragmentation at different stages of human T-lymphocyte development. Immunol Lett. 58:59–65. 1997. View Article : Google Scholar : PubMed/NCBI
10	Klein G: Cancer, apoptosis, and nonimmune surveillance. Cell Death Differ. 11:13–17. 2004. View Article : Google Scholar
11	Shimohama S: Apoptosis in Alzheimer's disease - an update. Apoptosis. 5:9–16. 2000. View Article : Google Scholar
12	Li M, Wu Z, Niu W, Wan Y, Zhang L, Shi G and Xi X: The protective effect of curcumin against the 19-kDa Mycobacterium tuberculosis protein-induced inflammation and apoptosis in human macrophages. Mol Med Rep. 10:3261–3267. 2014.PubMed/NCBI
13	Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, et al: Apoptosis in the failing human heart. N Engl J Med. 336:1131–1141. 1997. View Article : Google Scholar : PubMed/NCBI
14	Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW and Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1182–1189. 1996. View Article : Google Scholar : PubMed/NCBI
15	Ishino S, Kuge Y, Takai N, Tamaki N, Strauss HW, Blackenberg FG, Shiomi M and Saji H: 99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: Imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Eur J Nucl Med Mol Imaging. 34:889–899. 2007. View Article : Google Scholar : PubMed/NCBI
16	Li D, Williams V, Liu L, Chen H, Sawamura T, Romeo F and Mehta JL: Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol. 41:1048–1055. 2003. View Article : Google Scholar : PubMed/NCBI
17	Fliss H and Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:949–956. 1996. View Article : Google Scholar : PubMed/NCBI
18	Leung KP, Qu YH, Qiao DF, Xie WB, Li DR, Xu JT, Wang HJ and Yue X: Critical role of insulin-like growth factor binding protein-5 in methamphetamine-induced apoptosis in cardiomyocytes. Mol Med Rep. 10:2306–2312. 2014.PubMed/NCBI
19	Deng YJ, Tan N, Zeng HK, Fu YH and Dong XL: Effects of BNP preconditioning on myocardial cell apoptosis and expressions of bcl-2 and Bax during myocardial ischemia-reperfusion injury in rats. Zhonghua Yi Xue Za Zhi. 90:3431–3434. 2010.In Chinese.
20	Mattick JS and Makunin IV: Non-coding RNA. Hum Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
21	Yang Y, Li H, Hou S, Hu B, Liu J and Wang J: The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
22	Wang K, Long B, Zhou LY, Liu F, Zhou QY, Liu CY, Fan YY and Li PF: CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun. 5:35962014.PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Henriksen JH, Gøtze J, Fuglsang S, Christensen E, Bendtsen F and Møller S: Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: Relation to cardiovascular dysfunction and severity of disease. Gut. 52:1511–1517. 2003. View Article : Google Scholar : PubMed/NCBI
25	Smit B, Spoelstra-de Man AM, Girbes AR and de Waard MC: NT-proBNP in cardiopulmonary resuscitated patients treated with mild therapeutic hypothermia is not independently associated with mortality: a retrospective observational study. BMC anesthesiology. 15:482015. View Article : Google Scholar : PubMed/NCBI
26	Beer S, Golay S, Bardy D, Feihl F, Gaillard RC, Bachmann C, Waeber B and Ruiz J: Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications. Diabetes Metab. 31:567–573. 2005. View Article : Google Scholar : PubMed/NCBI
27	Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A and Hamm CW: N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol. 51:1188–1195. 2008. View Article : Google Scholar : PubMed/NCBI
28	Li Y, Song P, Zhu Q, Yin QY, Ji JW, Li W and Bian HM: Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure. Acta Pharmacol Sin. 35:1257–1264. 2014. View Article : Google Scholar : PubMed/NCBI
29	Suo C, Sun L and Yang S: Alpinetin activates the δ receptor instead of the κ and µreceptor pathways to protect against rat myocardial cell apoptosis. Exp Ther Med. 7:109–116. 2014.
30	Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, Müller W and Chien KR: Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell. 97:189–198. 1999. View Article : Google Scholar : PubMed/NCBI
31	Song XJ, Yang CY, Liu B, Wei Q, Korkor MT, Liu JY and Yang P: Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. Int J Med Sci. 8:564–572. 2011. View Article : Google Scholar : PubMed/NCBI
32	Kang PM and Izumo S: Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med. 9:177–182. 2003. View Article : Google Scholar : PubMed/NCBI
33	Mital S, Barbone A, Addonizio LJ, Quaegebeur JM, Mosca RJ, Oz MC and Hintze TH: Endogenous endothelium-derived nitric oxide inhibits myocardial caspase activity: Implications for treatment of end-stage heart failure. J Heart Lung Transplant. 21:576–585. 2002. View Article : Google Scholar : PubMed/NCBI
34	Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, et al: Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA. 96:8144–8149. 1999. View Article : Google Scholar : PubMed/NCBI
35	Liu Y, Wang J, Qi SY, Ru LS, Ding C, Wang HJ, Zhao JS, Li JJ, Li AY and Wang DM: Reduced endoplasmic reticulum stress might alter the course of heart failure via caspase-12 and JNK pathways. Can J Cardiol. 30:368–375. 2014. View Article : Google Scholar : PubMed/NCBI
36	Prescimone T, D'Amico A, Caselli C, Cabiati M, Viglione F, Caruso R, Verde A, Del Ry S, Trivella MG and Giannessi D: Caspase-1 transcripts in failing human heart after mechanical unloading. Cardiovasc Pathol. 24:11–18. 2015. View Article : Google Scholar
37	Syed FM, Hahn HS, Odley A, Guo Y, Vallejo JG, Lynch RA, Mann DL, Bolli R and Dorn GW II: Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia. Circ Res. 96:1103–1109. 2005. View Article : Google Scholar : PubMed/NCBI
38	Merkle S, Frantz S, Schön MP, Bauersachs J, Buitrago M, Frost RJ, Schmitteckert EM, Lohse MJ and Engelhardt S: A role for caspase-1 in heart failure. Circ Res. 100:645–653. 2007. View Article : Google Scholar : PubMed/NCBI
39	DeOcesano-Pereira C, Amaral MS, Par reira KS, Ayupe AC, Jacysyn JF, Amarante-Mendes GP, Reis EM and Verjovski-Almeida S: Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis. Nucleic Acids Res. 42:8343–8355. 2014. View Article : Google Scholar : PubMed/NCBI
40	Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu J, Wang DS, Song WJ and Dou KF: Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma. Int J Biol Sci. 10:664–676. 2014. View Article : Google Scholar : PubMed/NCBI